{"cluster": 43, "subcluster": 6, "abstract_summ": " The COVID-19 pandemic has caused a sense of unease in the rheumatology community about the risk to patients with immune-mediated diseases, given their predisposition to infection due to underlying disease states and immunosuppressive therapies . Patients with systemic sclerosis may be considered at risk for a more severe disease course and higher mortality when they develop SARS-CoV-2 infection ."}